Kit Conditional Knockout mouse models

Kit encodes the mouse ortholog of human KIT, a type III receptor tyrosine kinase with five extracellular immunoglobulin-like domains, an autoinhibitory juxtamembrane segment, and a split kinase domain that dimerizes upon binding stem cell factor (Kitl). Ligand engagement triggers trans-autophosphorylation and recruitment of PI3K, SRC family kinases, and the RAS-ERK cascade, sustaining mast cells, melanoblasts, hematopoietic progenitors, germ cells, and interstitial cells of Cajal. Oncogenic alleles fall into two mechanistic classes: juxtamembrane exon 11 deletions that relieve autoinhibition in gastrointestinal stromal tumor, and activation loop D816V substitutions that confer imatinib resistance in systemic mastocytosis and core binding factor leukemia. Conditional nulls therefore address lineage dependency, whereas knockin of the exact human hotspot codon models spontaneous tumorigenesis and inhibitor pharmacology; complete loss recapitulates the dominant white spotting phenotype with perinatal macrocytic anemia, so hypomorphic or inducible strategies preserve viability. Pair activating knockins with tissue-restricted Cre drivers to localize transformation and obtain clean drug response endpoints.

Conditional deletion of Kit limits the genetic change to the lineage you choose. That helps in oncology, immunology, and metabolic work where systemic loss would muddy the read. After you confirm Cre specificity, crossing to Kit floxed stock yields usable cohorts.